1 FRGS: Human Norovirus Replication In A Novel 3D Culture System Via Toll-Like Receptor (TLRs) Pathway And Modulation By Commensal Intestinal Bacteria
Principal Investigator: Assoc. Prof. Dr. Mudiana Muhamad
Amount: RM 224,800.
Duration:Dec 2019 – Jan 2023 (3 years)
2 FRGS: Mechanism of the enhancement of immune cells sensitization and trafficking in osteosarcoma by Spironolactone and Rosiglitazone towards adoptive immunotherapy in mice
Principal Investigator: Assoc. Prof. Dr. Sharaniza Ab. Rahim
Amount: RM 236,300.
Duration:Jan 2019 – Dec 2022 (3 years)
3 FRGS: Investigating the role of eosinophils in the progression of breast cancer in mouse model post-radiotherapy treatment
Principal Investigator: Dr. Mohammad Johari Ibahim
Amount: RM 179,800.
Duration:1st Sept 2019 – 31st Aug 2022
4 FRGS: Investigating the role of eosinophils in the progression of breast cancer in mouse model post-radiotherapy treatment
Principal Investigator: Mohammad Johari Ibahim
Amount: RM 123,200.
Duration: 1st August 2016 – 31st January 2020
5 FRGS-RACER: Lapatinib-Induced Changes In Caco-2 Intestinal Monolayer And Intervention With Recombinant Epidermal Growth Factor Receptor (rEGFR) 600-IRMI/FRGS-RACER 5/3 (018/2019)
Principal Investigator: Dr. Wan Nor I’zzah Wan Mohamad Zain
Amount: RM 51,200.00.
Duration:1st Sept 2019 – 31st Aug 2021
6 Bestari Perdana: Effect of Bisphenol A on the small intestinal tight junction proteins claudin 2, 3 and 4 in pregnant rats and their fetuses.
Principle invistigator: AP Dr. Jesmine Khan
Amount: RM 30,000.
Duration:1st Jan 2018 – 31st December 2019
7 LESTARI: Protective and antimicrobial mechanisms of anti-tetraspanins peptides against pseudomonas aeruginosa adherence to human keratinocytes.
Principle investigator: Dr. Emida Mohamed
Amount: RM 30,000
Duration:1 Sept 2018 – 31st Aug 2020
8 GIP: Role of eosinophils in the tumouregenic effect of breast cancer in mouse model post-radiotherapy treatment
Principle investigator: Dr. Mohammad Johari Ibahim
Amount: RM 25,000
Duration:1 Sept 2018 – 3 February 2020
8 BESTARI: Investigation of eosinophil granule proteins gene expression in human breast cancer cell line resistant to gamma-ray irradiation: in vitro and vivo studies
Principle investigator: Dr. Mohammad Johari Ibahim
Amount: RM 35,000
Duration:1 January 2018 – 31 December 2019